Onderzoeker
Kevin Punie
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf28 feb 2017 → Heden
Projecten
1 - 2 of 2
- Nieuwe biomerkers in de risicostratificatie, opvolging en behandeling van jonge patiënten met borstkankers en dragers van kiembaan pathogene varianten in TP53.Vanaf1 sep 2020 → 13 feb 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Terugval in borst- en gynaecologische kankers.Vanaf1 feb 2019 → 1 okt 2021Financiering: Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
21 - 30 van 75
- Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer(2021)
Auteurs: Kevin Punie
Pagina's: 1148 - 1156 - Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors.(2021)
Auteurs: Lisa Kinget, Oliver Bechter, Kevin Punie, Hilde Brems, Paul Clement, Eduard Roussel, Yannick Van Herck, Maarten Albersen, Marcella Baldewijns, Patrick Schöffski, et al.
Pagina's: 3227 - 3239 - Solving current dilemmas in the adjuvant endocrine treatment of pre- and perimenopausal women with an estrogen receptor positive breast cancer(2021)
Auteurs: Sileny Han, Kevin Punie, Hans Wildiers, Patrick Neven
Pagina's: 621 - 633 - Theconcerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II(2021)
Auteurs: Kevin Punie
- Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3(2021)
Auteurs: Lore De Cock, Jannes Heylen, Kevin Punie, Ann Smeets, Caroline Weltens, Patrick Neven, Annouschka Laenen, Hans Wildiers
Pagina's: 1 - 9 - Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study(2021)
Auteurs: Kevin Punie, Hans Wildiers
Pagina's: 1 - 12 - Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics.(2021)
Auteurs: Kevin Punie
Pagina's: 945 - 962 - Sacituzumab govitecan and trastuzumab deruxtecan: two new antibodyedrug conjugates in the breast cancer treatment landscape(2021)
Auteurs: Hans Wildiers, Patrick Neven, Kevin Punie
Pagina's: 1 - 13 - Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2-early breast cancer(2021)
Auteurs: Laurence Slembrouck, Isabelle Vanden Bempt, Hans Wildiers, Ann Smeets, Anne-Sophie Van Rompuy, Chantal Van Ongeval, Caroline Weltens, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, et al.
Pagina's: 1297 - 1309 - Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis(2021)
Auteurs: Kevin Punie